Novel EBP gene mutations in Conradi-Hünermann-Happle syndrome.
Br J Dermatol
; 157(6): 1225-9, 2007 Dec.
Article
em En
| MEDLINE
| ID: mdl-17949453
ABSTRACT
BACKGROUND:
Conradi-Hünermann-Happle syndrome [X-linked dominant chondrodysplasia punctata type 2 (CDPX2); MIM no. 302960] is an X-linked dominant disorder of cholesterol metabolism that causes a wide spectrum of skeletal abnormalities and linear ichthyosiform skin lesions. Mosaicism is probably responsible for the variability of the phenotype.OBJECTIVES:
To describe new mutations in patients with variable manifestations of the disease.METHODS:
We studied three patients with CDPX2. We performed mutation analysis of the EBP (formerly known as CDPX2) gene and gas chromatography-mass spectroscopy on serum of two patients.RESULTS:
We found two novel (3G-->T and 419-422delTTCT) and one known mutation in the EBP gene. We demonstrated the presence of increased levels of dehydrocholesterol and 8(9)-cholestenol in the two patients with new mutations, confirming the diagnosis of CDPX2 and strongly suggesting that the mutations are indeed pathogenic. One patient had a very mild phenotype, presenting with linear alopecia and a mild symmetrical epiphyseal dysplasia. X-inactivation studies in peripheral blood of all patients showed skewing in only the most severely affected patient.CONCLUSIONS:
The strong phenotypic variability in our patients suggests that there is no clear genotype-phenotype correlation.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Esteroide Isomerases
/
Condrodisplasia Punctata
Idioma:
En
Ano de publicação:
2007
Tipo de documento:
Article